Showing results (121-130 of 380) with videos related to

Sort By:
Pageof 38
International Journal of Clinical Practice|June 10, 2022
Opium Use and Cancer Risk: A Comprehensive Systematic Review and Meta-Analysis of Observational StudiesMasoume Mansouri, Sina Naghshi, Mahbobeh Parsaeian, et al.
BMC Public Health|October 21, 2016
A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa Cohort StudyMojtaba Farjam, Hossein Bahrami, Ehsan Bahramali, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 7, 2020
Circulating plasma fatty acids and risk of pancreatic cancer: Results from the Golestan Cohort StudyNeda Ghamarzad Shishavan, Ashraf Mohamadkhani, Sadaf Ghajarieh Sepanlou, et al.
Journal of Hepatology|November 6, 2007
Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3Hossein Poustchi, Francesco Negro, Jason Hui, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 29, 2014
Noninvasive measurement of liver fibrosis using transient elastography in pediatric patients with major thalassemia who are candidates for hematopoietic stem cell transplantationAmir Ali Hamidieh, Babak Shazad, Mohammad Reza Ostovaneh, et al.
Acta Diabetologica|June 15, 2019
Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patientsAsieh Mansour, Mohammad Reza Mohajeri-Tehrani, Majid Samadi, et al.
Archives of Iranian Medicine|August 6, 2023
Prevalence and Correlates of Polypharmacy, and Drug Utilization Pattern in a Semi-urban Population: Results from the Pars Cohort StudyMohammad Reza Akbari, Alireza Kamalipour, Mahsa Pakroo, et al.
Archives of Iranian Medicine|November 24, 2021
Prevalence, Pattern, and Correlates of Polypharmacy among Iranian Type II Diabetic Patients: Results from Pars Cohort StudyMahbobeh Azadi, Alireza Kamalipour, Hossein Molavi Vardanjani, et al.
Iranian Journal of Public Health|July 16, 2015
Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of IranBahareh Amirkalali, Hossein Poustchi, Hossein Keyvani, et al.
Nutrition Journal|April 11, 2021
Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trialAsieh Mansour, Mohammad Reza Mohajeri-Tehrani, Majid Samadi, et al.
Pageof 38